Nauset 4 mg/5 ml (Oral Solution)

50 ml bottle: ৳ 45.13

Medicine Details

Category	Details
Generic	Ondansetron
Company	Navana pharmaceuticals ltd
Also available as	Nauset 8 mg tablet Nauset 8 mg injection

Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy
Prevention and treatment of post-operative nausea and vomiting
Prevention of radiotherapy-induced nausea and vomiting

Ondansetron is a potent, highly selective 5HT3 receptor-antagonist. Its precise mode of action in the control of nausea and vomiting is not known.

Tear the pouch carefully along with the edge tear mark
Put the Ondansetron film on top of your tongue. It will dissolve within 20 seconds
Do not chew or swallow the film whole
Swallow after the Onsaf oral soluble film dissolves
Wash your hands after taking Onsaf oral soluble film

Nauset does not itself appear to induce or inhibit the cytochrome P-450 drug-metabolizing enzyme system of the liver.

Contraindicated in patients known to have hypersensitivity to the drug or any of its components. Concomitant use of apomorphine.

Carcinogenic effects were not seen in 2-year studies in rats and mice with oral Ondansetron doses up to 10 and 30 mg/kg per day, respectively
Ondansetron was not mutagenic in standard tests for mutagenicity
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron

Hypersensitivity reactions have been reported in patients who have exhibited hypersensitivity to other selective 5-HT3 receptor antagonists
Nauset is not a drug that stimulates gastric or intestinal peristalsis
The use of Nauset in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distension

Anti-emetic drugs

Store at temperature not exceeding 30°C in a dry place. Protect from light and moisture